chevron_leftBack
As of 5 June 2026, HLB Co., Ltd. has a market cap of $5.45B USD, ranking #3536 globally and #88 in South Korea.
It ranks #269 in the Healthcare sector, and #47 in the Biotechnology industry.
Key Stats
Market Cap
$5.45BUSD
8.37T KRW
Enterprise Value
$5.69BUSD
8.73T KRW
Revenue (TTM)
$54.76MUSD
84.17B KRW
EBITDA (TTM)
-$61.3MUSD
-93.95B KRW
Net Income (TTM)
-$143.44MUSD
-220.5B KRW
EBITDA Margin
-112%
Profit Margin
-262%
PS Ratio
99.5
PB Ratio
16.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Yoon Ki Baek
open_in_new
Employees
153
Founded
1975
Website
hlbbio.co.kr/
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.5% | 4% | 18% | -6.3% | 32% | 14% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
028300
에이치엘비(주)
ISIN: KR7028300002
Shares Out.:
Shares Outstanding:
132.939M1
Shares Float:
120.443M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
60,800 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About HLB Co., Ltd.
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. Additionally, it develops biological drugs with MoA to infectious diseases. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 207940
|
$44.36B
714%
68.19T KRW
|
35.5
|
|
KRX: 068270
|
$27.81B
411%
42.76T KRW
|
43.8
|
|
KRX: 196170
|
$13.23B
143%
20.33T KRW
|
146.6
|
|
KRX: 087010
|
$3.95B
-27%
6.07T KRW
|
-
|
|
KRX: 302440
|
$2.23B
-59%
3.42T KRW
|
-
|
|
KRX: 145020
|
$1.85B
-66%
2.84T KRW
|
20.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
3K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
3K%
|
19.0
|
|
EBR: ARGX
|
$48.01B
781%
41.39B EUR
|
39.9
|
|
ASX: CSL
|
$42.98B
689%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.55B
681%
33.71B CHF
|
37.2
|
|
NASDAQ: NTRA
|
$27.6B
407%
|
-
|
chevron_leftBack